Pediatric pharmacotherapy self assessment / / Sandra Benavides, Hanna Phan, Milap C. Nahata ; contributors, Mary A. Babico [and twenty-one others]

• Record Nr.: UNINA9910459912303321
• Autore: Benavides Sandra
• Pubbl/distr/stampa: Bethesda, Maryland : , : ASHP Publications, , 2015; ©2015
• ISBN: 1-58528-426-2
• Descrizione fisica: 1 online resource (285 p.)
• Disciplina: 615.1083
• Soggetti: Pediatric pharmacology; Electronic books.
• Lingua di pubblicazione: Inglese
• Formato: Materiale a stampa
• Livello bibliografico: Monografia
• Note generali: Description based upon print version of record.
• Nota di bibliografia: Includes bibliographical references at the end of each chapters and index.
• Nota di contenuto: ""titlepage""; ""table of contents""; ""contributors""; ""preface""; ""acknowledgments""; ""1.1 Pediatric Patient Care Management""; ""Part One - Cases""; ""CASE 2.1 Anaphylaxis | Level 1""; ""CASE 2.2 Nutrition | Level 2""; ""CASE 2.3 Toxicology | Level 3""; ""CASE 3.1 Patent Ductus Arteriosus | Level 1""; ""CASE 3.2 Hypertension | Level 2""; ""CASE 3.3 Congenital Heart Defects | Level 3""; ""CASE 4.1 Asthma | Level 1""; ""CASE 4.2 Cystic Fibrosis | Level 2""; ""CASE 4.3 Respiratory Distress Syndrome and Bronchopulmonary Dysplasia | Level 3""; ""CASE 5.1 Constipation | Level 1""; ""CASE 5.2 Crohn Disease | Level 2""""CASE 6.1 Nephrotic Syndrome | Level 2""; ""CASE 6.2 Acute Kidney Injury | Level 3""; ""CASE 7.1 Type 2 Diabetes Mellitus | Level 1""; ""CASE 7.2 Hypothyroidism | Level 2""; ""CASE 7.3 Diabetic Ketoacidosis | Level 3""; ""CASE 8.1 Attention Deficit Hyperactivity Disorder | Level 1""; ""CASE 8.2 Autism Spectrum Disorder | Level 2""; ""CASE 8.3 Depression | Level 2""; ""CASE 8.4 Cerebral Palsy | Level 3""; ""CASE 8.5 Seizure Disorders | Level 3""; ""CASE 9.1 Acute Otitis Media | Level 1""; ""CASE 9.2 Skin and Skin Structure Infections | Level 1""; ""CASE 9.3 Parasitic Infections | Level 2""""CASE 9.4 Pneumonia | Level 2""; ""CASE 9.5 Kawasaki Disease | Level 3""; ""CASE 9.6 Human ; Immunodeficiency Virus Infection | Level 3""; ""CASE 9.7 Meningitis | Level 3""; ""CASE 10.1 Anemia | Level 1""; ""CASE 10.2 Sickle Cell Disease | Level 2""; ""CASE 10.3 Anticoagulation | Level 3""; ""PART 2 | QUESTIONS & ANSWERS""; ""CASE 2.1 Anaphylaxis | Level 1""; ""CASE 2.2 Nutrition | Level 2""; ""CASE 2.3 Toxicology | Level 3""; ""CASE 3.1 Patent Ductus Arteriosus | Level 1""; ""CASE 3.2 Hypertension | Level 2""; ""CASE 3.3 Congenital Heart Defects | Level 3""""CASE 4.1 Asthma | Level 1""; ""CASE 4.2 Cystic Fibrosis | Level 2""; ""CASE 4.3 Respiratory Distress Syndrome and Bronchopulmonary Dysplasia | Level 3""; ""CASE 5.1 Constipation | Level 1""; ""CASE 5.2 Crohn Disease | Level 2""; ""CASE 6.1 Nephrotic Syndrome | Level 2""; ""CASE 6.2 Acute Kidney Injury | Level 3""; ""CASE 7.1 Type 2 Diabetes Mellitus | Level 1""; ""CASE 7.2 Hypothyroidism | Level 2""; ""CASE 7.3 Diabetic Ketoacidosis | Level 3""; ""CASE 8.1 Attention Deficit Hyperactivity Disorder | Level 1""; ""CASE 8.2 Autism Spectrum Disorder | Level 2""""CASE 8.3 Depression | Level 2""; ""CASE 8.4 Cerebral Palsy | Level 3""; ""CASE 8.5 Seizure Disorders | Level 3""; ""CASE 9.1 Acute Otitis Media | Level 1""; ""CASE 9.2 Skin and Skin Structure Infections | Level 1""; ""CASE 9.3 Parasitic Infections | Level 2""; ""CASE 9.4 Pneumonia | Level 2""; ""CASE 9.5 Kawasaki Disease | Level 3""; ""CASE 9.6 Human Immunodeficiency Virus Infection | Level 3""; ""CASE 9.7 Meningitis | Level 3""; ""CASE 10.1 Anemia | Level 1""; ""CASE 10.2 Sickle Cell Disease | Level 2""; ""CASE 10.3 Anticoagulation | Level 3""; ""APPENDIXES""